We showed that miR-323a-3p expression was reduced in advanced stage 4 tumors as compared to stage 1–2 and in MYCN-amplified (MNA) tumors as compared to non-MNA, two well-known prognostic factors of neuroblastoma (7). This evidence concerns the gene MYCN and neuroblastoma.